This inventor holds 3 USPTO granted patents. Top assignees: Lek Pharmaceuticals D.d., Lek, Tovarna Farmacevtskih, Lek, Tovarna, Farmacevtskih in Kemicnih . . .. Active years: 1994-2009.
Company Filing History:
1 out of 107 
1 out of 3 
1 out of 3 Years Active: 1994-2009
Title: Igor Krisch: Innovator in Pharmaceutical Treatments
Introduction
Igor Krisch is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the pharmaceutical industry, particularly in the treatment of addiction. With a total of 3 patents, his work focuses on innovative methods to address psychostimulant addiction.
Latest Patents
One of Igor Krisch's latest patents is centered on the treatment of psychostimulant addiction, specifically cocaine addiction. This invention introduces a new method that utilizes 9,10-didehydro-N-methyl-N-(2-propynyl)-6-methyl-8β-aminomethylergoline, which is effective in reducing abstinence symptoms and cravings associated with cocaine withdrawal. Additionally, this patent extends to the treatment of addictions related to amphetamines and their derivatives. Another significant patent involves a method for treating psychosis through the administration of ergolinyl derivatives of 2-propinylamine, showcasing his innovative approach to mental health treatments.
Career Highlights
Throughout his career, Igor Krisch has worked with prominent companies in the pharmaceutical sector, including Lek, Tovarna Farmacevtskih in Kemicnih, and Lek, Tovarna Farmacevtskih. His experience in these organizations has contributed to his expertise in developing effective pharmaceutical solutions.
Collaborations
Igor has collaborated with notable colleagues such as Rudolf Rucman and Breda Bole-Vunduk. These partnerships have further enriched his research and development efforts in the field of pharmaceuticals.
Conclusion
Igor Krisch stands out as an influential inventor in the pharmaceutical industry, particularly in the realm of addiction treatment. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.